RELFYDESS 100 units/ml, solution for injection bottle, 1.5 ml
Active ingredients: TOXINE BOTULINIQUE TYPE A
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 1.5 mlintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RELFYDESS 100 unités/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 flacon en verre de 1,5 mL (150 Unités)
- Marketing authorisation holder
- IPSEN PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 21 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- For professional use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65066375CIP73030172CIP133400930301722Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOXINE BOTULINIQUE TYPE Asolution | 100 Unités · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.